S3E9| David Regan + Nanotech and the Future of Cancer Treatment
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
S3E9| David Regan + Nanotech and the Future of Cancer Treatment
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Hosts James Collins and Alec Cranston return for a fresh episode packed with local stories, science, and innovation. The two sit with David Regan, CEO of Sona Nanotech. David shares the fascinating story behind Sona’s breakthrough gold nanorod technology, which enables targeted hyperthermia cancer therapy. We learn how these nanoparticles are tuned to specific wavelengths, injected into tumors, and then activated by near-infrared light to selectively destroy cancer cells while sparing healthy tissue. David explains the science, the company’s journey from rapid COVID-19 test development to cancer therapy, and the importance of Atlantic Canada’s innovation ecosystem.
Follow Matter Of 'Fax: https://www.instagram.com/matteroffaxpodcast/
Follow James: https://www.instagram.com/teamcollinsns/
Follow Alec: https://www.instagram.com/aleccranston9/
Follow the Reddit Roundup threads: https://www.reddit.com/r/halifax/comments/18jd9nw/nothing_says_grand_reopening_like_discount_broth/
https://www.reddit.com/r/halifax/s/btAf0ArhMh